Kathryn Giblin
AstraZeneca
Kathryn Giblin is listed at AstraZeneca. Kathryn is scheduled to speak at Big Data IV: breakthroughs in drug discovery with AI on 9 February 2027.
Compiled from published conference agendas; not yet confirmed by Kathryn. Is this you? Claim this profile.